| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |